Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy

Masato Furuhashi; Ichiro Sakuma; Takeshi Morimoto; Yukimura Higashiura; Akiko Sakai; Megumi Matsumoto; Mio Sakuma; Michio Shimabukuro; Takashi Nomiyama; Osamu Arasaki; Koichi Node; Shinichiro Ueda

doi:10.1186/s12933-020-01061-0

Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy

Cardiovascular Diabetology ◽

10.1186/s12933-020-01061-0 ◽

2020 ◽

Vol 19 (1) ◽

Cited By ~ 2

Author(s):

Masato Furuhashi ◽

Ichiro Sakuma ◽

Takeshi Morimoto ◽

Yukimura Higashiura ◽

Akiko Sakai ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Type 2 Diabetes Mellitus ◽

High Risk ◽

Statin Therapy

Download Full-text

1124-192 Rosiglitazone reduces novel biomarkers of cardiovascular disease in subjects with type 2 diabetes mellitus already on statin therapy

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(04)92131-6 ◽

2004 ◽

Vol 43 (5) ◽

pp. A504 ◽

Cited By ~ 2

Author(s):

John D Brunzell ◽

Santica Marcovina ◽

Dahong Yu ◽

Alexander Cobitz ◽

Errol Gould ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Type 2 Diabetes Mellitus ◽

Statin Therapy ◽

Novel Biomarkers

Download Full-text

PDB38 Budget IMPACT Analysis of Empagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus and High Risk or Established Atherosclerotic Cardiovascular Disease in Greece

Value in Health ◽

10.1016/j.jval.2020.08.635 ◽

2020 ◽

Vol 23 ◽

pp. S512

Author(s):

C. Tzanetakos ◽

G. Gourzoulidis ◽

N. Papanas ◽

G. Papageorgiou ◽

G. Karpouzos ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Type 2 Diabetes Mellitus ◽

High Risk ◽

Impact Analysis ◽

Budget Impact ◽

Budget Impact Analysis ◽

Atherosclerotic Cardiovascular Disease

Download Full-text

Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity

QJM ◽

10.1093/qjmed/hcn109 ◽

2008 ◽

Vol 101 (11) ◽

pp. 875-879 ◽

Cited By ~ 14

Author(s):

S.H. Song ◽

C.A. Hardisty

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Type 2 Diabetes Mellitus ◽

High Risk ◽

Risk Condition

Download Full-text

Abstract # P-18: Economic Burden of Type 2 Diabetes Mellitus in Patients with Cardiovascular Disease in Commercially-Insured Patients in the United States

Endocrine Practice ◽

10.1016/s1530-891x(20)43831-5 ◽

2016 ◽

Vol 22 ◽

pp. 21-22

Author(s):

Weijia Wang ◽

Eileen M. Farrelly ◽

Sharash Shetty ◽

Dana Stafkey-Mailey ◽

Stephen D. Sander ◽

...

Keyword(s):

Diabetes Mellitus ◽

United States ◽

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Type 2 Diabetes Mellitus ◽

Economic Burden ◽

The United States ◽

Insured Patients

Download Full-text

Statin therapy in type 2 diabetes mellitus is associated with increased circulating PCSK9 levels independent from liver disease

10.1055/s-0038-1641890 ◽

2018 ◽

Author(s):

B Stratmann ◽

M Hauber ◽

D Tschoepe

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Liver Disease ◽

Statin Therapy

Download Full-text

Autotaxin level in patients with type 2 diabetes mellitus or cardiovascular disease

Endocrine Abstracts ◽

10.1530/endoabs.63.p952 ◽

2019 ◽

Author(s):

Iffet Dağdelen Duran ◽

Neşe Ersoz Gulcelik

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Type 2 Diabetes Mellitus

Download Full-text

Effects of combined training according to HbA1c on atherogenic indices and cardiovascular disease risk factors in the type 2 diabetes mellitus

Exercise Science ◽

10.15857/ksep.2007.16.4.369 ◽

2007 ◽

Vol 16 (4) ◽

pp. 369-382 ◽

Cited By ~ 1

Author(s):

Hyungdon Kim ◽

김덕중

Keyword(s):

Diabetes Mellitus ◽

Risk Factors ◽

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Type 2 Diabetes Mellitus ◽

Disease Risk ◽

Cardiovascular Disease Risk ◽

Combined Training ◽

Atherogenic Indices

Download Full-text

Prevalence of Cardiovascular Disease Risk Factors among Qatari Patients with Type 2 Diabetes Mellitus, Attending Primary Health Care Centres, 2014

Journal of Community Medicine & Public Health ◽

10.29011/2577-2228.100073 ◽

2020 ◽

Vol 4 (01) ◽

Keyword(s):

Diabetes Mellitus ◽

Risk Factors ◽

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Health Care ◽

Type 2 Diabetes Mellitus ◽

Disease Risk ◽

Cardiovascular Disease Risk ◽

Primary Health

Download Full-text

Influence of Type 2 diabetes Mellitus with and without cardiovascular disease or myocardial infarction on levels of calcium, sodium, and some vital variables in Iraqi men

10.36295/asro.2020.232132 ◽

2020 ◽

Vol 23 (19) ◽

Author(s):

Safa S. Fayez ◽

Rashid M. Rashied ◽

Shakir F.T. Alaaraji

Keyword(s):

Diabetes Mellitus ◽

Myocardial Infarction ◽

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Type 2 Diabetes Mellitus

Download Full-text

198 Primary care use of SGLT2 inhibitors in patients with type 2 diabetes mellitus and cardiovascular disease – are we missing a trick?

10.1136/heartjnl-2021-bcs.194 ◽

2021 ◽

Author(s):

David Higson ◽

Andrew Turley

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Primary Care ◽

Type 2 Diabetes Mellitus ◽

Sglt2 Inhibitors

Download Full-text